Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
UCB
AddedFeb 13, 2024
UpdatedJun 28, 2026
UCB

UCB

Public

Belgium-based UCB SA is a global biopharmaceutical firm specializing in CNS disorders and inflammatory diseases.

HQ
City of Brussels, Flemish Brabant, BE
Founded
1928
Overview
Compare
Fundraising
Employees
News
Website

UCB is a global biopharmaceutical company headquartered in Brussels, Belgium. The company focuses on developing innovative solutions for people living with neurological and autoimmune conditions. UCB's mission is to create valuable treatments that improve the lives of patients, driven by the belief that everyone deserves to live their best life possible.

As a leader in the biopharmaceutical industry, UCB specializes in the treatment of central nervous system disorders and inflammatory diseases. The company works closely with patients, caregivers, and healthcare professionals to forge strong connections and deliver impactful solutions. UCB's approach combines scientific expertise with a patient-centric focus, aiming to make meaningful improvements in the lives of those affected by these conditions.

UCB - Similar Companies

Bristol Myers Squibb logo

Bristol Myers Squibb

bms.com

Janssen logo

Janssen

janssen.com

AstraZeneca logo

AstraZeneca

astrazeneca.com

Sanofi logo

Sanofi

sanofi.com

Catalyst Pharmaceuticals logo

Catalyst Pharmaceuticals

catalystpharma.com

Lonza logo

Lonza

Lundbeck logo

Lundbeck

lundbeck.com

Bayer Pharmaceuticals logo

Bayer Pharmaceuticals

bayer.com

Collegium Pharmaceutical logo

Collegium Pharmaceutical

Novartis logo

Novartis

novartis.com

Brii Biosciences logo

Brii Biosciences

briibio.com

Harmony Biosciences logo

Harmony Biosciences

Ferring logo

Ferring

ferring.com

AbbVie logo

AbbVie

abbvie.com

Kyntra Bio logo

Kyntra Bio

fibrogen.com

UCB - Quick Facts

Who are UCB's competitors?

Companies similar to UCB include Bristol Myers Squibb, Janssen, AstraZeneca and Sanofi.

When was UCB founded?

UCB was founded in 1928.

Where is UCB's headquarters located?

UCB's headquarters is located in City of Brussels, Flemish Brabant, BE.

When was UCB's last funding round?

UCB's most recent funding round was for $94.5M (USD) in May 2022.

How much has UCB raised to-date?

As of May 24, 2022, UCB has raised a total of $195.3M (USD).

How many employees does UCB have?

UCB has 7,600 employees as of Feb 6, 2024.

UCB - Classification

Ownership
  • Public
Technology
  • Biotech
Geographic Exposure
  • Global
Revenue
  • Recurring
  • Software
Customer
  • Enterprise
Main Product
  • Pharmaceuticals
Tags
  • Healthtech
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 325000Chemical Manufacturing
  • 325410Pharmaceutical and Medicine Manufacturing
  • 325412Pharmaceutical Preparation Manufacturing
SIC
  • 2800Chemicals And Allied Products
  • 2830Drugs
  • 2834Pharmaceutical Preparations
ISIC
  • 2100Manufacture of pharmaceuticals, medicinal chemical and botanical products
  • 6420Activities of holding companies
Show 15 more industry codes
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 620000Health Care and Social Assistance
  • 541000Professional, Scientific, and Technical Services
  • 623000Nursing and Residential Care Facilities
  • 541700Scientific Research and Development Services
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
SIC
  • 2100Tobacco Products
  • 2110Cigarettes
  • 8000Health Services
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8730Research, Development, And Testing Services
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified
  • 8731Commercial Physical and Biological Research